World Journal of Hepatology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 5532614

Number of visits today: 1937

Number of downloads: 3506478

PUBLISHING PARTNER

INDEXING/ABSTRACTING

MEMBERSHIP

BPG JOURNALS

Open-Access Journal

Other Issues: Previous | Next | Latest | Archive | Download full issue 3 (746)

Contents Volume 2 Issue 3 March 27, 2010

Editorial

Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis B

Konstantinos Tziomalos

World J Hepatol 2(3):91-93. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.91

Abstract (1001) | Core Tip (676) | Full Article (HTML) (2161) | Full Article (PDF)-515K (250) | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (6) | Total Visits (4226) | Similar Articles (1879) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Guidelines For Basic Science

Interactions of chemical carcinogens and genetic variation in hepatocellular carcinoma

Yu-Jing Zhang

World J Hepatol 2(3):94-102. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.94

Abstract (1017) | Core Tip (725) | Full Article (HTML) (3444) | Full Article (PDF)-707K (277) | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (27) | Total Visits (5609) | Similar Articles (1713) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Guidelines For Clinical Practice

Medical treatment of unresectable hepatocellular carcinoma: Going beyond sorafenib

Camillo Porta, Chiara Paglino

World J Hepatol 2(3):103-113. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.103

Abstract (1002) | Core Tip (692) | Full Article (HTML) (2673) | Figures (1-2) (310) | Tables (1-3) (296) | Full Article (PDF)-857K (291) | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (11) | Total Visits (5457) | Similar Articles (1713) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Review

Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma

Caecilia HC Sukowati, Natalia Rosso, Lory S Crocè, Claudio Tiribelli

World J Hepatol 2(3):114-126. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.114

Abstract (1098) | Core Tip (685) | Full Article (HTML) (6253) | Figures (1-3) (319) | Tables (1-2) (381) | Full Article (PDF)-880K (536) | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (37) | Total Visits (9461) | Similar Articles (1783) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Brief Article

Proteomic analysis for developing new biomarkers of hepatocellular carcinoma

Maria Pleguezuelo, Laura M Lopez-Sanchez, Antonio Rodriguez-Ariza, Jose L Montero, Javier Briceno, Ruben Ciria, Jordi Muntane, Manuel de la Mata

World J Hepatol 2(3):127-135. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.127

Abstract (1099) | Core Tip (676) | Full Article (HTML) (4107) | Figures (1-4) (272) | Tables (1-2) (314) | Full Article (PDF)-862K (506) | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (11) | Total Visits (7134) | Similar Articles (0) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Case Report

Granulocyte colony-stimulating factor as a novel adjunct to improve hepatitis B vaccination

Sudeep Tanwar, Mark Thursz

World J Hepatol 2(3):136-138. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.136

Abstract (1283) | Core Tip (723) | Full Article (HTML) (2322) | Full Article (PDF)-510K (231) | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (2) | Total Visits (4703) | Similar Articles (223) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Write to the Help Desk

© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345